Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $12.13 Average Target Price from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $12.13.

A number of brokerages have issued reports on BIOX. Lake Street Capital reduced their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Oppenheimer reduced their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, October 21st. Roth Mkm reduced their price target on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Finally, Canaccord Genuity Group reduced their price target on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research report on Wednesday, November 13th.

Bioceres Crop Solutions Price Performance

Shares of BIOX opened at $7.00 on Monday. The company has a market cap of $439.95 million, a P/E ratio of 350.18 and a beta of 0.49. The stock has a fifty day moving average price of $7.14 and a 200 day moving average price of $9.41. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. Bioceres Crop Solutions has a 12 month low of $5.71 and a 12 month high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). The company had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter in the previous year, the company earned ($0.07) earnings per share. On average, research analysts forecast that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Institutional Trading of Bioceres Crop Solutions

Several institutional investors have recently modified their holdings of the company. Oak Family Advisors LLC lifted its holdings in shares of Bioceres Crop Solutions by 1.9% in the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after buying an additional 1,208 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares during the period. Stifel Financial Corp lifted its holdings in shares of Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. Lazard Asset Management LLC acquired a new position in shares of Bioceres Crop Solutions in the 1st quarter valued at $212,000. Finally, Ping Capital Management Inc. purchased a new position in Bioceres Crop Solutions in the 2nd quarter worth about $448,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.